AstraZeneca COVID-19 TACKLE Treatment Study

COVID-19 Treatment Trials in Columbus

Aventiv Research is currently participating in an investigational COVID-19 treatment study at our Columbus, Ohio location. We are currently enrolling adults who have tested positive for COVID-19 within the last three days.

Enroll Now

AstraZeneca COVID-19 TACKLE Study

The primary objective of this clinical trial is to estimate the efficacy of an investigational drug compared to placebo for the treatment of COVID-19 in adults with mild to moderate symptoms of COVID-19. You may be eligible to participate if you meet the following criteria:

• You are  at least 18 years old
• Have a laboratory-confirmed SARS-CoV-2 infection, as determined by a antigen or nucleic acid test collected no more than 3 days before starting the trial
• You are currently not hospitalized
• You have one or more of the following symptoms:
  • Subjective fever or feeling feverish
  • Cough
  • Shortness of breath or difficulty breathing at rest or with activity
  • Sore throat
  • Body pain or muscle pain/aches
  • Fatigue
  • Headache
  • Chills
  • Nasal obstruction or congestion
  • Nasal discharge
  • New loss of taste or smell
  • Nausea or vomiting
  • Diarrhea
  • New onset confusion (only for participants at least 60 years old)
  • Appetite loss or decreased food intake (only for participants at least 60 years old)
  • Increased supplemental oxygen requirement (only for participants on baseline supplemental oxygen)

As a part of our ongoing commitment to protect your health and safety, we’re practicing enhanced safety measures at our clinical research sites.